Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global Tumor Suppressor Factor M market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 214 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Oncostatin M (OSM) is a growth differentiation factor involved in the regulation of neurogenesis, osteogenesis, and hematopoiesis. It stimulates the proliferation of fibroblasts, smooth muscle cells, and Kaposi's sarcoma cells, but inhibits the growth of some normal and tumor cell lines. It also promotes the release of cytokines (such as IL-6, GM-CSF, and g-CSF) from endothelial cells and enhances the expression of low-density lipoprotein receptors in hepatoma cells. OSM is produced by activated T cells, monocytes, and Kaposi's sarcoma cells and has stimulatory and inhibitory effects on cell proliferation.
Tumor Suppressor Factor M Market Size(US$)
M= millions and B=billions

In 2025, the North America Tumor Suppressor Factor M market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Tumor Suppressor Factor M include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Tumor Suppressor Factor M market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
Report Metric
Details
Report Title
Global Tumor Suppressor Factor M Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Forecasted Market Size in 2032
US$ 214 million
CAGR(2026-2032)
9.0%
Market Size Available for Years
2026-2032
Global Tumor Suppressor Factor M Companies Covered
Thermo Fisher Scientific Inc.
Bio-Techne
Scientists Helping Scientists
Abcam Limited
FUJIFILM Irvine Scientific
BD Biosciences
Bio-Rad Laboratories, Inc.
BPS Bioscience, Inc.
Elabscience
Yisheng Biotechnology (Shanghai) Co., Ltd.
ENZO
Beijing Biocreative Technology Co., Ltd.
Shanghai Yaji Biotechnology Co., Ltd.
Cellverse Co., Ltd.
Dalian Meilun Biotech Co., Ltd.
Sino Biological,Inc.
Prospec-Tany Technogene Ltd
Global Tumor Suppressor Factor M Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tumor Suppressor Factor M Market, Segment by Type
Purity<95%
Purity ≥95%
Global Tumor Suppressor Factor M Market, Segment by Application
University
Research Center
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Tumor Suppressor Factor M sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Tumor Suppressor Factor M manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Tumor Suppressor Factor M product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tumor Suppressor Factor M value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Table of Contents
1 Market Overview
1.1 Tumor Suppressor Factor M Product Scope
1.2 Tumor Suppressor Factor M by Type
1.2.1 Global Tumor Suppressor Factor M Sales by Type (2021, 2025 & 2032)
1.2.2 Purity<95%
1.2.3 Purity ≥95%
1.3 Tumor Suppressor Factor M by Application
1.3.1 Global Tumor Suppressor Factor M Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 University
1.3.3 Research Center
1.4 Global Tumor Suppressor Factor M Market Estimates and Forecasts (2021-2032)
1.4.1 Global Tumor Suppressor Factor M Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Tumor Suppressor Factor M Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Tumor Suppressor Factor M Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Tumor Suppressor Factor M Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Tumor Suppressor Factor M Historical Market Scenario by Region (2021-2026)
2.2.1 Global Tumor Suppressor Factor M Sales Market Share by Region (2021-2026)
2.2.2 Global Tumor Suppressor Factor M Revenue Market Share by Region (2021-2026)
2.3 Global Tumor Suppressor Factor M Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Tumor Suppressor Factor M Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Tumor Suppressor Factor M Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Tumor Suppressor Factor M Market Size and Prospects (2021-2032)
2.4.2 Europe Tumor Suppressor Factor M Market Size and Prospects (2021-2032)
2.4.3 China Tumor Suppressor Factor M Market Size and Prospects (2021-2032)
2.4.4 Japan Tumor Suppressor Factor M Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Tumor Suppressor Factor M Historical Market Review by Type (2021-2026)
3.1.1 Global Tumor Suppressor Factor M Sales by Type (2021-2026)
3.1.2 Global Tumor Suppressor Factor M Revenue by Type (2021-2026)
3.1.3 Global Tumor Suppressor Factor M Average Price by Type (2021-2026)
3.2 Global Tumor Suppressor Factor M Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Tumor Suppressor Factor M Sales Forecast by Type (2027-2032)
3.2.2 Global Tumor Suppressor Factor M Revenue Forecast by Type (2027-2032)
3.2.3 Global Tumor Suppressor Factor M Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Tumor Suppressor Factor M
4 Global Market Size by Application
4.1 Global Tumor Suppressor Factor M Historical Market Review by Application (2021-2026)
4.1.1 Global Tumor Suppressor Factor M Sales by Application (2021-2026)
4.1.2 Global Tumor Suppressor Factor M Revenue by Application (2021-2026)
4.1.3 Global Tumor Suppressor Factor M Average Price by Application (2021-2026)
4.2 Global Tumor Suppressor Factor M Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Tumor Suppressor Factor M Sales Forecast by Application (2027-2032)
4.2.2 Global Tumor Suppressor Factor M Revenue Forecast by Application (2027-2032)
4.2.3 Global Tumor Suppressor Factor M Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Tumor Suppressor Factor M Applications
5 Competition Landscape by Players
5.1 Global Tumor Suppressor Factor M Sales by Player (2021-2026)
5.2 Global Top Tumor Suppressor Factor M Players by Revenue (2021-2026)
5.3 Global Tumor Suppressor Factor M Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Tumor Suppressor Factor M revenue as of 2025
5.4 Global Tumor Suppressor Factor M Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Tumor Suppressor Factor M, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Tumor Suppressor Factor M, Product Type & Application
5.7 Global Key Manufacturers of Tumor Suppressor Factor M, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Tumor Suppressor Factor M Sales by Company
6.1.1.1 North America Tumor Suppressor Factor M Sales by Company (2021-2026)
6.1.1.2 North America Tumor Suppressor Factor M Revenue by Company (2021-2026)
6.1.2 North America Tumor Suppressor Factor M Sales Breakdown by Type (2021-2026)
6.1.3 North America Tumor Suppressor Factor M Sales Breakdown by Application (2021-2026)
6.1.4 North America Tumor Suppressor Factor M Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Tumor Suppressor Factor M Sales by Company
6.2.1.1 Europe Tumor Suppressor Factor M Sales by Company (2021-2026)
6.2.1.2 Europe Tumor Suppressor Factor M Revenue by Company (2021-2026)
6.2.2 Europe Tumor Suppressor Factor M Sales Breakdown by Type (2021-2026)
6.2.3 Europe Tumor Suppressor Factor M Sales Breakdown by Application (2021-2026)
6.2.4 Europe Tumor Suppressor Factor M Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Tumor Suppressor Factor M Sales by Company
6.3.1.1 China Tumor Suppressor Factor M Sales by Company (2021-2026)
6.3.1.2 China Tumor Suppressor Factor M Revenue by Company (2021-2026)
6.3.2 China Tumor Suppressor Factor M Sales Breakdown by Type (2021-2026)
6.3.3 China Tumor Suppressor Factor M Sales Breakdown by Application (2021-2026)
6.3.4 China Tumor Suppressor Factor M Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Tumor Suppressor Factor M Sales by Company
6.4.1.1 Japan Tumor Suppressor Factor M Sales by Company (2021-2026)
6.4.1.2 Japan Tumor Suppressor Factor M Revenue by Company (2021-2026)
6.4.2 Japan Tumor Suppressor Factor M Sales Breakdown by Type (2021-2026)
6.4.3 Japan Tumor Suppressor Factor M Sales Breakdown by Application (2021-2026)
6.4.4 Japan Tumor Suppressor Factor M Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Thermo Fisher Scientific Inc.
7.1.1 Thermo Fisher Scientific Inc. Company Information
7.1.2 Thermo Fisher Scientific Inc. Business Overview
7.1.3 Thermo Fisher Scientific Inc. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Thermo Fisher Scientific Inc. Tumor Suppressor Factor M Products Offered
7.1.5 Thermo Fisher Scientific Inc. Recent Development
7.2 Bio-Techne
7.2.1 Bio-Techne Company Information
7.2.2 Bio-Techne Business Overview
7.2.3 Bio-Techne Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Bio-Techne Tumor Suppressor Factor M Products Offered
7.2.5 Bio-Techne Recent Development
7.3 Scientists Helping Scientists
7.3.1 Scientists Helping Scientists Company Information
7.3.2 Scientists Helping Scientists Business Overview
7.3.3 Scientists Helping Scientists Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Scientists Helping Scientists Tumor Suppressor Factor M Products Offered
7.3.5 Scientists Helping Scientists Recent Development
7.4 Abcam Limited
7.4.1 Abcam Limited Company Information
7.4.2 Abcam Limited Business Overview
7.4.3 Abcam Limited Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Abcam Limited Tumor Suppressor Factor M Products Offered
7.4.5 Abcam Limited Recent Development
7.5 FUJIFILM Irvine Scientific
7.5.1 FUJIFILM Irvine Scientific Company Information
7.5.2 FUJIFILM Irvine Scientific Business Overview
7.5.3 FUJIFILM Irvine Scientific Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.5.4 FUJIFILM Irvine Scientific Tumor Suppressor Factor M Products Offered
7.5.5 FUJIFILM Irvine Scientific Recent Development
7.6 BD Biosciences
7.6.1 BD Biosciences Company Information
7.6.2 BD Biosciences Business Overview
7.6.3 BD Biosciences Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.6.4 BD Biosciences Tumor Suppressor Factor M Products Offered
7.6.5 BD Biosciences Recent Development
7.7 Bio-Rad Laboratories, Inc.
7.7.1 Bio-Rad Laboratories, Inc. Company Information
7.7.2 Bio-Rad Laboratories, Inc. Business Overview
7.7.3 Bio-Rad Laboratories, Inc. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Bio-Rad Laboratories, Inc. Tumor Suppressor Factor M Products Offered
7.7.5 Bio-Rad Laboratories, Inc. Recent Development
7.8 BPS Bioscience, Inc.
7.8.1 BPS Bioscience, Inc. Company Information
7.8.2 BPS Bioscience, Inc. Business Overview
7.8.3 BPS Bioscience, Inc. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.8.4 BPS Bioscience, Inc. Tumor Suppressor Factor M Products Offered
7.8.5 BPS Bioscience, Inc. Recent Development
7.9 Elabscience
7.9.1 Elabscience Company Information
7.9.2 Elabscience Business Overview
7.9.3 Elabscience Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Elabscience Tumor Suppressor Factor M Products Offered
7.9.5 Elabscience Recent Development
7.10 Yisheng Biotechnology (Shanghai) Co., Ltd.
7.10.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
7.10.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
7.10.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Tumor Suppressor Factor M Products Offered
7.10.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
7.11 ENZO
7.11.1 ENZO Company Information
7.11.2 ENZO Business Overview
7.11.3 ENZO Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.11.4 ENZO Tumor Suppressor Factor M Products Offered
7.11.5 ENZO Recent Development
7.12 Beijing Biocreative Technology Co., Ltd.
7.12.1 Beijing Biocreative Technology Co., Ltd. Company Information
7.12.2 Beijing Biocreative Technology Co., Ltd. Business Overview
7.12.3 Beijing Biocreative Technology Co., Ltd. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Beijing Biocreative Technology Co., Ltd. Tumor Suppressor Factor M Products Offered
7.12.5 Beijing Biocreative Technology Co., Ltd. Recent Development
7.13 Shanghai Yaji Biotechnology Co., Ltd.
7.13.1 Shanghai Yaji Biotechnology Co., Ltd. Company Information
7.13.2 Shanghai Yaji Biotechnology Co., Ltd. Business Overview
7.13.3 Shanghai Yaji Biotechnology Co., Ltd. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Shanghai Yaji Biotechnology Co., Ltd. Tumor Suppressor Factor M Products Offered
7.13.5 Shanghai Yaji Biotechnology Co., Ltd. Recent Development
7.14 Cellverse Co., Ltd.
7.14.1 Cellverse Co., Ltd. Company Information
7.14.2 Cellverse Co., Ltd. Business Overview
7.14.3 Cellverse Co., Ltd. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Cellverse Co., Ltd. Tumor Suppressor Factor M Products Offered
7.14.5 Cellverse Co., Ltd. Recent Development
7.15 Dalian Meilun Biotech Co., Ltd.
7.15.1 Dalian Meilun Biotech Co., Ltd. Company Information
7.15.2 Dalian Meilun Biotech Co., Ltd. Business Overview
7.15.3 Dalian Meilun Biotech Co., Ltd. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Dalian Meilun Biotech Co., Ltd. Tumor Suppressor Factor M Products Offered
7.15.5 Dalian Meilun Biotech Co., Ltd. Recent Development
7.16 Sino Biological,Inc.
7.16.1 Sino Biological,Inc. Company Information
7.16.2 Sino Biological,Inc. Business Overview
7.16.3 Sino Biological,Inc. Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Sino Biological,Inc. Tumor Suppressor Factor M Products Offered
7.16.5 Sino Biological,Inc. Recent Development
7.17 Prospec-Tany Technogene Ltd
7.17.1 Prospec-Tany Technogene Ltd Company Information
7.17.2 Prospec-Tany Technogene Ltd Business Overview
7.17.3 Prospec-Tany Technogene Ltd Tumor Suppressor Factor M Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Prospec-Tany Technogene Ltd Tumor Suppressor Factor M Products Offered
7.17.5 Prospec-Tany Technogene Ltd Recent Development
8 Tumor Suppressor Factor M Manufacturing Cost Analysis
8.1 Tumor Suppressor Factor M Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Tumor Suppressor Factor M
8.4 Tumor Suppressor Factor M Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Tumor Suppressor Factor M Distributors List
9.3 Tumor Suppressor Factor M Customers
10 Tumor Suppressor Factor M Market Dynamics
10.1 Tumor Suppressor Factor M Industry Trends
10.2 Tumor Suppressor Factor M Market Drivers
10.3 Tumor Suppressor Factor M Market Challenges
10.4 Tumor Suppressor Factor M Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Tumor Suppressor Factor M Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Tumor Suppressor Factor M Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Tumor Suppressor Factor M Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Tumor Suppressor Factor M Sales (K Units) by Region (2021-2026)
Table 5. Global Tumor Suppressor Factor M Sales Market Share by Region (2021-2026)
Table 6. Global Tumor Suppressor Factor M Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Tumor Suppressor Factor M Revenue Share by Region (2021-2026)
Table 8. Global Tumor Suppressor Factor M Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Tumor Suppressor Factor M Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Tumor Suppressor Factor M Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Tumor Suppressor Factor M Revenue Share Forecast by Region (2027-2032)
Table 12. Global Tumor Suppressor Factor M Sales by Type (K Units) & (2021-2026)
Table 13. Global Tumor Suppressor Factor M Sales Share by Type (2021-2026)
Table 14. Global Tumor Suppressor Factor M Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Tumor Suppressor Factor M Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Tumor Suppressor Factor M Sales by Type (K Units) & (2027-2032)
Table 17. Global Tumor Suppressor Factor M Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Tumor Suppressor Factor M Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Tumor Suppressor Factor M Sales by Application (K Units) & (2021-2026)
Table 21. Global Tumor Suppressor Factor M Sales Share by Application (2021-2026)
Table 22. Global Tumor Suppressor Factor M Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Tumor Suppressor Factor M Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Tumor Suppressor Factor M Sales by Application (K Units) & (2027-2032)
Table 25. Global Tumor Suppressor Factor M Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Tumor Suppressor Factor M Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Tumor Suppressor Factor M Applications
Table 28. Global Tumor Suppressor Factor M Sales by Company (K Units) & (2021-2026)
Table 29. Global Tumor Suppressor Factor M Sales Share by Company (2021-2026)
Table 30. Global Tumor Suppressor Factor M Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Tumor Suppressor Factor M Revenue Share by Company (2021-2026)
Table 32. Global Tumor Suppressor Factor M by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Suppressor Factor M as of 2025)
Table 33. Global Market Tumor Suppressor Factor M Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Tumor Suppressor Factor M, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Tumor Suppressor Factor M, Product Type & Application
Table 36. Global Key Manufacturers of Tumor Suppressor Factor M, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Tumor Suppressor Factor M Sales by Company (2021-2026) & (K Units)
Table 39. North America Tumor Suppressor Factor M Sales Market Share by Company (2021-2026)
Table 40. North America Tumor Suppressor Factor M Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Tumor Suppressor Factor M Revenue Market Share by Company (2021-2026)
Table 42. North America Tumor Suppressor Factor M Sales by Type (2021-2026) & (K Units)
Table 43. North America Tumor Suppressor Factor M Sales Market Share by Type (2021-2026)
Table 44. North America Tumor Suppressor Factor M Sales by Application (2021-2026) & (K Units)
Table 45. North America Tumor Suppressor Factor M Sales Market Share by Application (2021-2026)
Table 46. Europe Tumor Suppressor Factor M Sales by Company (2021-2026) & (K Units)
Table 47. Europe Tumor Suppressor Factor M Sales Market Share by Company (2021-2026)
Table 48. Europe Tumor Suppressor Factor M Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Tumor Suppressor Factor M Revenue Market Share by Company (2021-2026)
Table 50. Europe Tumor Suppressor Factor M Sales by Type (2021-2026) & (K Units)
Table 51. Europe Tumor Suppressor Factor M Sales Market Share by Type (2021-2026)
Table 52. Europe Tumor Suppressor Factor M Sales by Application (2021-2026) & (K Units)
Table 53. Europe Tumor Suppressor Factor M Sales Market Share by Application (2021-2026)
Table 54. China Tumor Suppressor Factor M Sales by Company (2021-2026) & (K Units)
Table 55. China Tumor Suppressor Factor M Sales Market Share by Company (2021-2026)
Table 56. China Tumor Suppressor Factor M Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Tumor Suppressor Factor M Revenue Market Share by Company (2021-2026)
Table 58. China Tumor Suppressor Factor M Sales by Type (2021-2026) & (K Units)
Table 59. China Tumor Suppressor Factor M Sales Market Share by Type (2021-2026)
Table 60. China Tumor Suppressor Factor M Sales by Application (2021-2026) & (K Units)
Table 61. China Tumor Suppressor Factor M Sales Market Share by Application (2021-2026)
Table 62. Japan Tumor Suppressor Factor M Sales by Company (2021-2026) & (K Units)
Table 63. Japan Tumor Suppressor Factor M Sales Market Share by Company (2021-2026)
Table 64. Japan Tumor Suppressor Factor M Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Tumor Suppressor Factor M Revenue Market Share by Company (2021-2026)
Table 66. Japan Tumor Suppressor Factor M Sales by Type (2021-2026) & (K Units)
Table 67. Japan Tumor Suppressor Factor M Sales Market Share by Type (2021-2026)
Table 68. Japan Tumor Suppressor Factor M Sales by Application (2021-2026) & (K Units)
Table 69. Japan Tumor Suppressor Factor M Sales Market Share by Application (2021-2026)
Table 70. Thermo Fisher Scientific Inc. Company Information
Table 71. Thermo Fisher Scientific Inc. Description and Business Overview
Table 72. Thermo Fisher Scientific Inc. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. Thermo Fisher Scientific Inc. Tumor Suppressor Factor M Product
Table 74. Thermo Fisher Scientific Inc. Recent Development
Table 75. Bio-Techne Company Information
Table 76. Bio-Techne Description and Business Overview
Table 77. Bio-Techne Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Bio-Techne Tumor Suppressor Factor M Product
Table 79. Bio-Techne Recent Development
Table 80. Scientists Helping Scientists Company Information
Table 81. Scientists Helping Scientists Description and Business Overview
Table 82. Scientists Helping Scientists Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Scientists Helping Scientists Tumor Suppressor Factor M Product
Table 84. Scientists Helping Scientists Recent Development
Table 85. Abcam Limited Company Information
Table 86. Abcam Limited Description and Business Overview
Table 87. Abcam Limited Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Abcam Limited Tumor Suppressor Factor M Product
Table 89. Abcam Limited Recent Development
Table 90. FUJIFILM Irvine Scientific Company Information
Table 91. FUJIFILM Irvine Scientific Description and Business Overview
Table 92. FUJIFILM Irvine Scientific Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. FUJIFILM Irvine Scientific Tumor Suppressor Factor M Product
Table 94. FUJIFILM Irvine Scientific Recent Development
Table 95. BD Biosciences Company Information
Table 96. BD Biosciences Description and Business Overview
Table 97. BD Biosciences Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. BD Biosciences Tumor Suppressor Factor M Product
Table 99. BD Biosciences Recent Development
Table 100. Bio-Rad Laboratories, Inc. Company Information
Table 101. Bio-Rad Laboratories, Inc. Description and Business Overview
Table 102. Bio-Rad Laboratories, Inc. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Bio-Rad Laboratories, Inc. Tumor Suppressor Factor M Product
Table 104. Bio-Rad Laboratories, Inc. Recent Development
Table 105. BPS Bioscience, Inc. Company Information
Table 106. BPS Bioscience, Inc. Description and Business Overview
Table 107. BPS Bioscience, Inc. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. BPS Bioscience, Inc. Tumor Suppressor Factor M Product
Table 109. BPS Bioscience, Inc. Recent Development
Table 110. Elabscience Company Information
Table 111. Elabscience Description and Business Overview
Table 112. Elabscience Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Elabscience Tumor Suppressor Factor M Product
Table 114. Elabscience Recent Development
Table 115. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
Table 116. Yisheng Biotechnology (Shanghai) Co., Ltd. Description and Business Overview
Table 117. Yisheng Biotechnology (Shanghai) Co., Ltd. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Yisheng Biotechnology (Shanghai) Co., Ltd. Tumor Suppressor Factor M Product
Table 119. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development
Table 120. ENZO Company Information
Table 121. ENZO Description and Business Overview
Table 122. ENZO Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. ENZO Tumor Suppressor Factor M Product
Table 124. ENZO Recent Development
Table 125. Beijing Biocreative Technology Co., Ltd. Company Information
Table 126. Beijing Biocreative Technology Co., Ltd. Description and Business Overview
Table 127. Beijing Biocreative Technology Co., Ltd. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Beijing Biocreative Technology Co., Ltd. Tumor Suppressor Factor M Product
Table 129. Beijing Biocreative Technology Co., Ltd. Recent Development
Table 130. Shanghai Yaji Biotechnology Co., Ltd. Company Information
Table 131. Shanghai Yaji Biotechnology Co., Ltd. Description and Business Overview
Table 132. Shanghai Yaji Biotechnology Co., Ltd. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Shanghai Yaji Biotechnology Co., Ltd. Tumor Suppressor Factor M Product
Table 134. Shanghai Yaji Biotechnology Co., Ltd. Recent Development
Table 135. Cellverse Co., Ltd. Company Information
Table 136. Cellverse Co., Ltd. Description and Business Overview
Table 137. Cellverse Co., Ltd. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Cellverse Co., Ltd. Tumor Suppressor Factor M Product
Table 139. Cellverse Co., Ltd. Recent Development
Table 140. Dalian Meilun Biotech Co., Ltd. Company Information
Table 141. Dalian Meilun Biotech Co., Ltd. Description and Business Overview
Table 142. Dalian Meilun Biotech Co., Ltd. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Dalian Meilun Biotech Co., Ltd. Tumor Suppressor Factor M Product
Table 144. Dalian Meilun Biotech Co., Ltd. Recent Development
Table 145. Sino Biological,Inc. Company Information
Table 146. Sino Biological,Inc. Description and Business Overview
Table 147. Sino Biological,Inc. Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Sino Biological,Inc. Tumor Suppressor Factor M Product
Table 149. Sino Biological,Inc. Recent Development
Table 150. Prospec-Tany Technogene Ltd Company Information
Table 151. Prospec-Tany Technogene Ltd Description and Business Overview
Table 152. Prospec-Tany Technogene Ltd Tumor Suppressor Factor M Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Prospec-Tany Technogene Ltd Tumor Suppressor Factor M Product
Table 154. Prospec-Tany Technogene Ltd Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Tumor Suppressor Factor M Distributors List
Table 158. Tumor Suppressor Factor M Customers List
Table 159. Tumor Suppressor Factor M Market Trends
Table 160. Tumor Suppressor Factor M Market Drivers
Table 161. Tumor Suppressor Factor M Market Challenges
Table 162. Tumor Suppressor Factor M Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Suppressor Factor M Product Picture
Figure 2. Global Tumor Suppressor Factor M Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Tumor Suppressor Factor M Sales Market Share by Type in 2025 & 2032
Figure 4. Purity<95% Product Picture
Figure 5. Purity ≥95% Product Picture
Figure 6. Global Tumor Suppressor Factor M Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 7. Global Tumor Suppressor Factor M Sales Market Share by Application in 2025 & 2032
Figure 8. University Examples
Figure 9. Research Center Examples
Figure 10. Global Tumor Suppressor Factor M Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 11. Global Tumor Suppressor Factor M Sales Growth Rate (2021-2032) & (US$ Million)
Figure 12. Global Tumor Suppressor Factor M Sales (K Units) Growth Rate (2021-2032)
Figure 13. Global Tumor Suppressor Factor M Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 14. Tumor Suppressor Factor M Report Years Considered
Figure 15. Global Market Tumor Suppressor Factor M Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 16. Global Tumor Suppressor Factor M Revenue Market Share by Region: 2021 VS 2025
Figure 17. North America Tumor Suppressor Factor M Revenue (US$ Million) Growth Rate (2021-2032)
Figure 18. North America Tumor Suppressor Factor M Sales (K Units) Growth Rate (2021-2032)
Figure 19. Europe Tumor Suppressor Factor M Revenue (US$ Million) Growth Rate (2021-2032)
Figure 20. Europe Tumor Suppressor Factor M Sales (K Units) Growth Rate (2021-2032)
Figure 21. China Tumor Suppressor Factor M Revenue (US$ Million) Growth Rate (2021-2032)
Figure 22. China Tumor Suppressor Factor M Sales (K Units) Growth Rate (2021-2032)
Figure 23. Japan Tumor Suppressor Factor M Revenue (US$ Million) Growth Rate (2021-2032)
Figure 24. Japan Tumor Suppressor Factor M Sales (K Units) Growth Rate (2021-2032)
Figure 25. Global Tumor Suppressor Factor M Revenue Share by Type (2021-2026)
Figure 26. Global Tumor Suppressor Factor M Sales Share by Type (2027-2032)
Figure 27. Global Tumor Suppressor Factor M Revenue Share by Type (2027-2032)
Figure 28. Global Tumor Suppressor Factor M Revenue Share by Application (2021-2026)
Figure 29. Global Tumor Suppressor Factor M Revenue Market Share by Application in 2021 & 2025
Figure 30. Global Tumor Suppressor Factor M Sales Share by Application (2027-2032)
Figure 31. Global Tumor Suppressor Factor M Revenue Share by Application (2027-2032)
Figure 32. Global Tumor Suppressor Factor M Sales Share by Company (2025)
Figure 33. Global Tumor Suppressor Factor M Revenue Share by Company (2025)
Figure 34. Global 5 Largest Tumor Suppressor Factor M Players Market Share by Revenue in Tumor Suppressor Factor M: 2021 & 2025
Figure 35. Tumor Suppressor Factor M Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 36. Manufacturing Cost Structure of Tumor Suppressor Factor M
Figure 37. Manufacturing Process Analysis of Tumor Suppressor Factor M
Figure 38. Tumor Suppressor Factor M Industrial Chain
Figure 39. Channels of Distribution (Direct Vs Distribution)
Figure 40. Distributors Profiles
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives InterviewedDescription
The global Tumor Suppressor Factor M market size was US$ 118 million in 2025 and is forecast to reach a readjusted size of US$ 214 million by 2032 with a CAGR of 9.0% during the forecast period 2026-2032.
Oncostatin M (OSM) is a growth differentiation factor involved in the regulation of neurogenesis, osteogenesis, and hematopoiesis. It stimulates the proliferation of fibroblasts, smooth muscle cells, and Kaposi's sarcoma cells, but inhibits the growth of some normal and tumor cell lines. It also promotes the release of cytokines (such as IL-6, GM-CSF, and g-CSF) from endothelial cells and enhances the expression of low-density lipoprotein receptors in hepatoma cells. OSM is produced by activated T cells, monocytes, and Kaposi's sarcoma cells and has stimulatory and inhibitory effects on cell proliferation.
In 2025, the North America Tumor Suppressor Factor M market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Tumor Suppressor Factor M include Thermo Fisher Scientific Inc., Bio-Techne, Scientists Helping Scientists, Abcam Limited, FUJIFILM Irvine Scientific, BD Biosciences, Bio-Rad Laboratories, Inc., BPS Bioscience, Inc., Elabscience, Yisheng Biotechnology (Shanghai) Co., Ltd., among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Tumor Suppressor Factor M market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Tumor Suppressor Factor M sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Tumor Suppressor Factor M manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Tumor Suppressor Factor M product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tumor Suppressor Factor M value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Related Reports
The global Tumor Suppressor Factor M market is projected to grow from US$ 118 million in 2025 to US$ 198 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
Published: 2025-05-09
Pages: 180
USD 4900.00
(Single User License)
The global market for Tumor Suppressor Factor M was estimated to be worth US$ 107 million in 2024 and is forecast to a readjusted size of US$ 198 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-09
Pages: 146
USD 3950.00
(Single User License)
The global market for Tumor Suppressor Factor M was valued at US$ 107 million in the year 2024 and is projected to reach a revised size of US$ 198 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-05-09
Pages: 104
USD 2900.00
(Single User License)
The global Tumor Suppressor Factor M market size was US$ 107 million in 2024 and is forecast to a readjusted size of US$ 198 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-09
Pages: 106
USD 4250.00
(Single User License)
The global market for Tumor Suppressor Factor M was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 214 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-09
Pages: 145
USD 3950.00
(Single User License)
The global Tumor Suppressor Factor M market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 214 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-11
Pages: 133
USD 2900.00
(Single User License)
The global Tumor Suppressor Factor M market is projected to grow from US$ 118 million in 2025 to US$ 214 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 177
USD 4900.00
(Single User License)
The global Tumor Suppressor Factor M market is projected to grow from US$ 118 million in 2025 to US$ 198 million by 2031, at a Compound Annual Growth Rate (CAGR) of 9.0% during the forecast period.
Published: 2025-05-09
Pages: 180
The global market for Tumor Suppressor Factor M was estimated to be worth US$ 107 million in 2024 and is forecast to a readjusted size of US$ 198 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-09
Pages: 146
The global market for Tumor Suppressor Factor M was valued at US$ 107 million in the year 2024 and is projected to reach a revised size of US$ 198 million by 2031, growing at a CAGR of 9.0% during the forecast period.
Published: 2025-05-09
Pages: 104
The global Tumor Suppressor Factor M market size was US$ 107 million in 2024 and is forecast to a readjusted size of US$ 198 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Published: 2025-05-09
Pages: 106
The global market for Tumor Suppressor Factor M was estimated to be worth US$ 118 million in 2025 and is projected to reach US$ 214 million, growing at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-09
Pages: 145
The global Tumor Suppressor Factor M market was valued at US$ 118 million in 2025 and is anticipated to reach US$ 214 million by 2032, at a CAGR of 9.0% from 2026 to 2032.
Published: 2026-03-11
Pages: 133
The global Tumor Suppressor Factor M market is projected to grow from US$ 118 million in 2025 to US$ 214 million by 2032, at a CAGR of 9.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 177
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database